Position in PHAT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$326,288
-$145,846 QoQ
Shares Held
29,369
+3.2% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,808,560 across 402 Biotechnology names. PHAT ranks #139 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in PHAT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $326,288 | 29,369 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $472,134 | 28,459 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $160,482 | 13,635 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $4,960,397 | 517,247 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $3,328,484 | 530,859 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $361,964 | 44,577 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $569,899 | 31,521 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $91,216 | 8,856 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $64,197 | 6,045 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $51,575 | 5,649 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $39,696 | 3,828 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $130,082 | 9,084 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $6,754 | 946 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $12,701 | 1,132 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $13,816 | 1,247 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $21,175 | 2,509 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $28,526 | 2,096 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $146,561 | 7,451 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $175,908 | 5,480 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $96,134 | 2,840 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $69,372 | 1,847 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $109,426 | 3,294 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $40,996 | 1,118 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $107,352 | 3,262 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $83,681 | 3,241 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||